Lambat Zaynab, Limson Janice L, Daya Santy
Faculty of Pharmacy, Rhodes University, Box 94 Grahamstown, 6140, South Africa.
J Pharm Pharmacol. 2002 Dec;54(12):1681-6. doi: 10.1111/j.2042-7158.2002.tb02404.x.
Cimetidine is one of the most potent H(2) receptor antagonists for inhibiting excessive histamine-induced acid secretion and is currently used worldwide to treat peptic ulcers. In this study, levels of free radicals were assessed and the ability of cimetidine to act as an antioxidant was determined using nitroblue-tetrazolium assay and lipid peroxidation assays. Free radical generation in the brain is promoted by the presence of iron, as occurs in the Fenton reaction. The results show that cimetidine reduces the generation of superoxide anion formed in the nitroblue-tetrazolium assay. In addition, cimetidine (1 mM) is able to reduce the iron-induced rise in lipid peroxidation in rat brain homogenates. Electrochemistry, UV/Vis spectroscopy and HPLC experiments show metal-ligand interactions between cimetidine and transition metals. The results imply that cimetidine provides a neuroprotective effect by binding to iron and copper, thus making them unavailable for free radical production.
西咪替丁是抑制组胺诱导的胃酸过度分泌的最强效H(2)受体拮抗剂之一,目前在全球范围内用于治疗消化性溃疡。在本研究中,使用硝基蓝四唑试验和脂质过氧化试验评估自由基水平,并确定西咪替丁作为抗氧化剂的能力。铁的存在会促进大脑中自由基的产生,就像芬顿反应中那样。结果表明,西咪替丁可减少硝基蓝四唑试验中形成的超氧阴离子的产生。此外,西咪替丁(1 mM)能够降低铁诱导的大鼠脑匀浆脂质过氧化的升高。电化学、紫外/可见光谱和高效液相色谱实验表明西咪替丁与过渡金属之间存在金属-配体相互作用。结果表明,西咪替丁通过与铁和铜结合发挥神经保护作用,从而使它们无法用于自由基的产生。